Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 785,930 | 817,258 | 639,113 | 606,417 | 690,846 |
| Cost of Goods | 191,122 | 169,631 | 147,591 | 149,048 | 148,739 |
| Gross Profit | 594,808 | 647,626 | 491,522 | 457,463 | 542,200 |
| Operating Expenses | 390,680 | 1,053,839 | 387,578 | 330,130 | 389,804 |
| Operating Income | 204,359 | -405,476 | 104,535 | 127,380 | 153,137 |
| Interest Expense | 18,926 | 17,657 | 22,356 | 24,576 | 28,872 |
| Other Income | -1,532 | -105 | 0 | 0 | 8,230 |
| Pre-tax Income | 183,901 | -423,238 | 82,179 | 102,805 | 132,495 |
| Income Tax | 39,712 | -118,973 | 16,560 | 20,730 | 3,887 |
| Net Income Continuous | 144,189 | -304,265 | 65,619 | 82,075 | 128,608 |
| Minority Interests | N/A | N/A | -207 | N/A | N/A |
| Net Income | $144,189 | $-304,159 | $65,826 | $82,075 | $129,175 |
| EPS Basic Total Ops | 0.42 | -0.88 | 0.19 | 0.24 | 0.38 |
| EPS Basic Continuous Ops | 0.42 | -0.88 | 0.19 | 0.24 | 0.38 |
| EPS Diluted Total Ops | 0.41 | -0.87 | 0.19 | 0.24 | 0.37 |
| EPS Diluted Continuous Ops | 0.41 | -0.87 | 0.19 | 0.24 | 0.37 |
| EPS Diluted Before Non-Recurring Items | 0.45 | 0.64 | 0.24 | 0.26 | 0.37 |
| EBITDA(a) | $289,801 | $387,169 | $205,645 | $215,271 | $237,364 |